While gluten challenges are rarely offered to those who have been off gluten but are looking to reintroduce it, knowledge regarding the duration of gluten challenge and gluten dosage is insufficient. Researchers in BMC Gastroenterology challenged adult celiac patients with gluten with a view to assessing the amount needed to cause some small-bowel mucosal deterioration. Subjects were challenged with low (1-3 g) or moderate (3-5g) doses of gluten daily for 12 weeks. Both moderate and low amounts of gluten induced small-bowel morphological damage in 67% of celiac patients. Moderate gluten doses also triggered mucosal inflammation and more gastrointestinal symptoms leading to premature withdrawals in numerous cases. In 22% of those who developed significant small- intestinal damage, symptoms remained absent. Celiac antibodies seroconverted in 43% of the patients.
Diagnosing Celiac in Children.
Archives of Disease in Childhood published new guidelines from a panel of European experts for screening children for celiac disease. Here is the list:
- Testing for celiac disease (CD) should be offered to children and young people with otherwise unexplained gastrointestinal symptoms and signs and, in addition, those children with unexplained poor growth, delayed puberty, iron deficiency anaemia, chronic abdominal pain, constipation, recurrent aphthous stomatitis and abnormal liver biochemistry.
- There should be testing of asymptomatic individuals known to have an increased risk of CD: that is, patients with type I diabetes mellitus, Down's syndrome, autoimmune thyroid disease, Turner's syndrome, Williams' syndrome, selective IgA deficiency, autoimmune liver disease and first degree relatives with CD.
- Typing for HLA-DQ2 and HLA-DQ8 can be a useful tool to exclude CD and it is a negative result that is most useful, as this virtually excludes CD.
- HLA testing should be performed in cases where there is an uncertain diagnosis of CD (eg, cases with negative CD specific antibodies and mild changes on proximal small intestinal biopsy specimens).
- If CD is considered in children where there is a strong clinical suspicion of CD, highly specific CD antibodies are present and small bowel biopsies are not going to be performed, the recommendation is that HLA-DQ2/HLA-DQ8 typing is required to add strength to the diagnosis.
- Anti-gliadin antibody testing is no longer recommended, although a further antibody test against anti-deamidated gliadin peptide antibody may provide further specificity in cases of doubt, particularly in children under 2 years of age.